/AUPH

Aurinia Pharmaceuticals Inc

AUPH

$16.10USD↓-0.06%-0.01 today

MARKET CAP

2.1B

P/E (TTM)

7.5x

FWD P/E

—

DAY RANGE

$16 – $16

52W RANGE

$10

$19

AI Summary

Stalk

Buy NowMedium

We see a constructive medium-term backdrop underpinned by a Bullish Pivot Point pattern signaling failed downside control and upward mean reversion. Price is pulling back into the 50-day SMA and converged 9/20 EMAs, offering a disciplined entry near rising support. The long-term trend remains bullish under a rising 200-day SMA. We recommend Buy Now to capitalize on the pullback interaction at key moving averages.

↑Total 2025 revenue reached $283.1M, up 20% YoY.
↑Q4 Lupkinis sales surged 29% to $74.2M.
↓FDA information request fuels regulatory uncertainty.

Full analysis →

Buying

7

institutions

Selling

6

institutions

New Positions

1

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	8.19 M	139.04 M	+347.56 K	+19.6%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	1.55 M	26.27 M	+-115.80 K	+6.5%	0.04%
JH Janus Henderson Group Plc Q1 2026	BUY	1.51 M	22.45 M	+824.24 K	+103.8%	0.01%
AC Aqr Capital Management LLC Q2 2026	SELL	948.75 K	16.10 M	+-59.00	+14.5%	0.01%
CA Citadel Advisors LLC Q2 2026	BUY	465.19 K	7.89 M	+58.51 K	+31.0%	0.00%
WP Woodline Partners LP Q2 2026	SELL	456.26 K	7.74 M	+-456.26 K	-42.8%	0.02%
VI Voloridge Investment Management, LLC Q2 2026	SELL	362.42 K	6.15 M	+-165.76 K	-21.4%	0.03%
JC Jpmorgan Chase & Co Q2 2026	SELL	291.35 K	4.98 M	+-32.33 K	+10.0%	0.00%
MM Millennium Management LLC Q2 2026	BUY	244.30 K	4.15 M	+127.13 K	+138.8%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	BUY	210.00 K	3.56 M	+126.00 K	+186.3%	0.82%
BA Balyasny Asset Management L.P. Q2 2026	BUYNEW	88.24 K	1.50 M	+88.24 K	+0.0%	0.00%
MG Man Group Plc Q2 2026	SELL	83.89 K	1.42 M	+-867.52 K	-89.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	24.77 K	420.35 K	+911.00	+18.9%	0.00%